These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 36246586)
1. Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment. Wu W; Dong J; Lv Y; Chang D Front Genet; 2022; 13():984158. PubMed ID: 36246586 [TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
3. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X Front Oncol; 2023; 13():1152681. PubMed ID: 37333810 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer. Li L; Sun F; Kong F; Feng Y; Song Y; Du Y; Liu F; Kong X Front Oncol; 2023; 13():1083956. PubMed ID: 37384293 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J Front Genet; 2023; 14():1094793. PubMed ID: 36891150 [No Abstract] [Full Text] [Related]
6. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Li Y; Zeng X Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728 [No Abstract] [Full Text] [Related]
7. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P Front Immunol; 2022; 13():919231. PubMed ID: 35967366 [TBL] [Abstract][Full Text] [Related]
8. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L Front Genet; 2023; 14():1056000. PubMed ID: 36845390 [No Abstract] [Full Text] [Related]
9. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma. Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer. Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429 [TBL] [Abstract][Full Text] [Related]
11. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma. Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497 [TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer. Chu B; Wang Y; Yang J; Dong B Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879 [TBL] [Abstract][Full Text] [Related]
13. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses. Xu C; Liu Y; Zhang Y; Gao L Front Genet; 2022; 13():928105. PubMed ID: 36313449 [No Abstract] [Full Text] [Related]
14. A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients. Bai WD; Liu JY; Li M; Yang X; Wang YL; Wang GJ; Li SC World J Oncol; 2022 Oct; 13(5):299-310. PubMed ID: 36406193 [TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma. Chen Y Front Genet; 2022; 13():912037. PubMed ID: 35937995 [No Abstract] [Full Text] [Related]
16. The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma. Sun P; Xu H; Zhu K; Li M; Han R; Shen J; Xia X; Chen X; Fei G; Zhou S; Wang R Front Genet; 2022; 13():1061382. PubMed ID: 36531222 [No Abstract] [Full Text] [Related]
17. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer. Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F J Oncol; 2022; 2022():5034092. PubMed ID: 36276275 [TBL] [Abstract][Full Text] [Related]
18. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617 [TBL] [Abstract][Full Text] [Related]
19. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Li J; Yin J; Li W; Wang H; Ni B Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma. Zhou Z; Zhou Y; Liu D; Yang Q; Tang M; Liu W Front Pharmacol; 2022; 13():1074123. PubMed ID: 36588699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]